58
Diabetes Mellitus and Musculoskeletal System Dr Hossein Soleymani Assistant Prof of Rheumatology SSMU, Jan 2015, YAZD, IRAN

Dr Hossein Soleymani Assistant Prof of Rheumatology SSMU, Jan 2015, YAZD, IRAN

Embed Size (px)

Citation preview

  • Slide 1
  • Dr Hossein Soleymani Assistant Prof of Rheumatology SSMU, Jan 2015, YAZD, IRAN
  • Slide 2
  • Slide 3
  • Introduction MS complaint more frequent Metabolic change in CV tissue Glycolysation of proteins Microvascular abnormality Accumulation of extracellular matrix and soft tissue More seen in longstanding type I Some complications have direct association
  • Slide 4
  • Pathogenesis: An increase in non-enzymatic glycosylation of collagen fiber Increase collagen crosslink Resistant to enzymatic digestion Increase in hydration mediated by aldolase reductase pathway Increased formation Advanced Glycosylation End product (AGEs)
  • Slide 5
  • Pathogenesis: AGEs causes micro and macro vascular complications AGEs result from early glycolysation Accumulate in tissue Damage extra and intra cellular proteins There are receptors on cell surface for AGEs belong to IG receptors Signaling lead to cell dysfunction AGEs decrease vascular elasticity
  • Slide 6
  • Slide 7
  • Slide 8
  • Slide 9
  • Condition limited to DM Diabetic Muscle Infarction
  • Slide 10
  • Conditions more frequently in DM Diabetic cheiroarthrophaty (stiff hand synd) Trigger finger (flexor tenosynovitis) Dupuytrens contracture Carpal tunnel syndrome Adhesive shoulder capsulitis (frozen shoulder)Calcific shoulder tendonitis Reflex sympathetic dystrophy ( shoulder-hand syndrome) Diabetic osteoarthrophaty or charcota or neuropathic arthropathy
  • Slide 11
  • Conditions Sharing Risk Factors of DM Diffuse Idiopathic Skeletal Hyperostosis Gout/ Pseudogout Osteoarthritis
  • Slide 12
  • Hand Diabetic cheiroathrophaty or diabetic stiff hand or limited mobility joint syndrome: 8% to 50% all type I DM,45%-70% type II Associated and predictor of other complication Thick, tight, waxy skin, begin in MCP&PIP 5 Like systemic sclerosis Limited joint mobility( finger flex and extend)
  • Slide 13
  • Cheiroarthropathy Lack of following differentiated from Scledrema: Raynuads phenomena, dermal atrophy, telangiectasia and autoantibodies Nail fold capillaroscopic change may be seen Both type I and type II have higher prevalence retinopathy and nephropathy
  • Slide 14
  • hand Flexion contracture of fingers cause Prayer sign
  • Slide 15
  • Cheiroarthropathy
  • Slide 16
  • Recommended treatment: 1- Glycemic control 2- Physical therapy 3- NSAIDs with caution
  • Slide 17
  • Hand: Trigger finger Catching sensation or locking phenomena Pain in affected finger Thumb, then third and forth 5%-36% type I, II (2% normal) Palpable nodule overlying MCP joint Thickening along the affected flexor tendon Prevalence related to duration of DM TF in 3 or more finger highly suggestive for DM
  • Slide 18
  • Slide 19
  • Slide 20
  • Trigger Finger Treatments: 1-Change of activity 2- Splint 3- Use of NSAIDs with caution 4- CS injection 5- In severe case surgery
  • Slide 21
  • Hand: Dupuytrens contracture Thickening, shortening, fibrosis of palmar facia Nodule along the facia causes flexion contractures of the finger Usually fourth but may be seen II to V fingers 16% to 42% of all DM more in eldery May be seen in early stage Prevalence more in longstanding DM
  • Slide 22
  • Dupuytrens contracture More in third and fourth finger More in women Manifestations are more severe in men
  • Slide 23
  • Slide 24
  • Slide 25
  • Dupuytrens contracture Treatments: 1- Intralesional injection of CS 2- Surgery 3- Physical therapy 4- Some studies show benefit from injection of collagenase Colstridium Histolyticum
  • Slide 26
  • Hand: Carpal Tunnel syndrome 20% of diabetic patients more in women More in obbes Median nerve entrapment Caused by diabetic-induced connective tissue alteration HX & PE Tinels sign, Phalens test In dubious case Electrophysiological studies helpfull
  • Slide 27
  • Slide 28
  • Slide 29
  • Carpal tunnel syndrome Treatments: 1- Splint, NSAIDs 2- Injection CS: response may be temporary and poorer in DM 3- Release surgery: post operative recovery is worse
  • Slide 30
  • Shoulder: Frozen shoulder Frozen shoulder or adhesive capsulitis Most common shoulder involvement 10-29% diabetic patients, bilateral, elderly Stiffness Glenohumeral joint Reversible contraction joint capsule See in hyperthyroidism, Addison and Parkinson
  • Slide 31
  • Slide 32
  • Adhesive capsulitis Progressive and painful manner Pain at night initially Three phase:(a) Pain (b) Stiffness (c) Recovery Diagnostic criteria by Pal: Shoulder pain at least one month, impossibility lying's one shoulder, limited active and passive movement Decreased range of motion in abduction and external rotation then internal rotation
  • Slide 33
  • Slide 34
  • Adhesive capsulitis Treatments: 1- Analgesic 2- Physiotherapy 3- CS injection 4- Arthroscopy release
  • Slide 35
  • Shoulder: Calcific shoulder tendonitis Three times more frequent in DM (type II) Coexist with adhesive capsulitis Deposit Ca hydroxy apatite Ca depostion in rotator cuff tendons 60% asymptomatic
  • Slide 36
  • Sohulder:Reflex sympathetic dystrophy Shoulder-hand synd or complex regional pain synd Pain from shoulder to hand Swelling of affected limb Skin change: hair growth, shiny skin, color, temperature Increased sensitivity to pain and touch Vasomotor instability Transit patchy osteoporosis
  • Slide 37
  • Slide 38
  • Slide 39
  • Feet: Charcots arthropathy Diabetic osteoarthropathy Rare: 0.1% to 0.4% Both type DM Average duration 15 years Advanced peripheral neuropathy
  • Slide 40
  • Feet: Charcots arthropathy Loss of sensation in involved joint Inadvertent microtrauma to joint Consecutive degenerative change Severe destruction, lytic joint changes Most affect pedal bones
  • Slide 41
  • Feet: Charcots arthropathy Erythema, swelling, hyperpimentation Purpura, soft tissue ulcer Joint loosening, instability, joint deformity Often no history of trauma
  • Slide 42
  • Slide 43
  • Feet: Charcots arthropathy Diagnosis: based on radiographic findings Symptoms often milder than view of X-ray X-raysubluxation, bone fragment, osteolysis Periosteal reaction, deformity, ankylosis
  • Slide 44
  • Slide 45
  • Feet: Charcots arthropathy CT sacn is insensitive MRI and bone scintigraphy adjuncts X-ray DD: Inflammatory, degenerative, infections, tumors, DVT
  • Slide 46
  • Charcot arthropathy Treatments: 1- Prevent weight bearing on affected joint 2- Bisphosphanate 3- Calcitonin may be useful
  • Slide 47
  • Muscle: Diabetic muscle infarction Rare condition Spontaneous infraction with no history of trauma Patients with long history of poorly controlled DM More in insulin requiring patients Most patients show microvascular complications like neuropathy, retinopathy, nephropathy
  • Slide 48
  • Muscle: Diabetic muscle infarction Acute onset of pain and swelling on affected M Over days to weeks Usually thigh or calf Varying degree of tenderness CPK may be normal or increased
  • Slide 49
  • Slide 50
  • Muscle: Diabetic muscle infarction D&D: Tumor, muscle infection/abscess, localized myositis, osteomyelitis, thrombosis CT Scan in insensitive MRI show high signals in muscle in T2 When incisional muscle biopsy? Only to rule out infection and malignancy (culture for atypical organisms) Treatments: rest, analgesic
  • Slide 51
  • Slide 52
  • Slide 53
  • Diffuse Skeletal Disease Diffuse idiopathic skeletal hyperostosis(DISH) Metaplastic calcification of spinal ligament Osteophyte formation Disc space, sacroiliac and facet joint: normal Thoracic spine most commonly affected May be accompanied by generalized calcification of other ligament
  • Slide 54
  • Diffuse Idiopathic Skeletal Hyperostosis Unknown etiology IN DM patients more than normal Association with type II DM More in obese patients Pain is not prominent symptoms Complaint stiffness in neck and back Decreased range of motion
  • Slide 55
  • Slide 56
  • Slide 57
  • Other disease with DM Osteoporosis: controversy, risk of Fx increased Osteoarthritis Hyperurecemia
  • Slide 58
  • Thanks For Your Attention